The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge

Journal of Clinical Pharmacy and Therapeutics

Volumn 38, Issue 2, 2013, Pages 97-100

  Hassan, Y ^a   Kassab, Y ^b   Abd Aziz, N ^a   Akram, H ^b   Ismail, O ^c  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^b SCHOOL OF PHYSICS   (Malaysia)

^c HOSPITAL PULAU PINANG   (Malaysia)

Author keywords

acute coronary syndrome; drug utilization; pharmacist initiated interventions; secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; CARDIOTONIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PHARMACIST; PRESCRIPTION; PREVENTION AND CONTROL; RETROSPECTIVE STUDY; SECONDARY PREVENTION; MIDDLE AGED; PROCEDURES;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PHARMACISTS; PRESCRIPTIONS; RETROSPECTIVE STUDIES; SECONDARY PREVENTION;

EID: 84875001358     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12027     Document Type: Article

References (15)

1. Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O, Avezum A., Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J, 2002; 23: 1177-1189.
2. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J, 2001; 22: 554-572.
3. Chew DP, Amerena J, Coverdale S, Rankin J, Astley C, Brieger D,. Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. Intern Med J, 2007; 37: 741-748.
4. Kassab YW, Hassan Y, Abd Aziz N, Akram H, &, Ismail O,. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice. J Eval Clin Pract, 2012; doi: 10.1111/j.13652753.2012. 01894.x
5. NHAM. Clinical Practice Guidelines-Management of Unstable Angina/Non ST Elevation Myocardial Infarction (UA/NSTEMI). [Online]. 2011. Available at: http://www.malaysianheart.org/article.php?aid=631 (Accessed 25 June 2011).
6. NHAM. Clinical Practice Guidelines-Management of Acute ST segment Elevation Myocardial Infarction (STEMI) 2007, 2nd edn. [Online]. 2007. Available at: http://www.malaysianheart.org/article.php?aid=135 (Accessed 25 June 2011).
7. Chapman N, Fotis M, Yarnold P, Gheorghiade M,. Pharmacist interventions to improve the management of coronary artery disease. Am J Health Syst Pharm, 2004; 61: 2672-2678.
8. Grimshaw J, Thomas R, MacLennan G, et al,. Effectiveness and efciency of guideline dissemination and implementation strategies. Int J Technol Assess, 2005; 21: 149.
9. Grol R, Grimshaw J,. From best evidence to best practice: effective implementation of change in patients' care. Lancet, 2003; 362: 1225-1230.
10. Grindrod KA, Patel P, Martin JE,. What interventions should pharmacists employ to impact health practitioners' prescribing practices? Ann Pharmacother, 2006; 40: 1546-1557.
11. Yusuf S,. Two decades of progress in preventing vascular disease. Lancet, 2002; 360: 2-3.
12. Ornstein S, Jenkins RG, Nietert PJ, et al,. A Multimethod Quality Improvement Intervention To Improve Preventive Cardiovascular Care. A Cluster Randomized Trial. Ann Intern Med, 2004; 141: 523-532.
13. Lee TH, Pearson SD, Johnson PA, et al,. Failure of Information as an Intervention to Modify Clinical Management: a Time-Series Trial in Patients with Acute Chest Pain. Ann Intern Med, 1995; 122: 434-437.
14. Axtell SS, Ludwig E, Lopez-Candales A,. Intervention to improve adherence to ACC/AHA recommended adjunctive medications for the management of patients with an acute myocardial infarction. Clin Cardiol, 2001; 24: 114-118.
15. Sarasin FP, Maschiangelo M-L, Schaller M-D, Héliot C, Mischler S, Gaspoz J-M,. Successful implementation of guidelines for encouraging the use of beta blockers in patients after acute myocardial infarction. Am J Med, 1999; 106: 499-505.